Details for Patent: 11,628,150
✉ Email this page to a colleague
Which drugs does patent 11,628,150 protect, and when does it expire?
Patent 11,628,150 protects GIMOTI and is included in one NDA.
This patent has ten patent family members in seven countries.
Drugs Protected by US Patent 11,628,150
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Evoke Pharma Inc | GIMOTI | metoclopramide hydrochloride | SPRAY, METERED;NASAL | 209388-001 | Jun 19, 2020 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | NASAL ADMINISTRATION OF METOCLOPRAMIDE FOR TREATMENT OF DIABETIC GASTROPARESIS | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,628,150
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2780485 | ⤷ Subscribe | |||
| Canada | 2984736 | ⤷ Subscribe | |||
| Canada | 3155873 | ⤷ Subscribe | |||
| Canada | 3224872 | ⤷ Subscribe | |||
| Denmark | 2376075 | ⤷ Subscribe | |||
| European Patent Office | 2376075 | ⤷ Subscribe | |||
| Spain | 2536885 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
